GO:0031073 cholesterol 26-hydroxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031073 cholesterol 26-hydroxylase activity is a mitochondrial cytochrome P450 molecular function that converts cholesterol to 26-hydroxycholesterol using NADPH and oxygen.
• The reaction is stereo- and regio-specific, generating 26-hydroxycholesterol (also known as 27-hydroxycholesterol), a key regulatory oxysterol.
• In humans, the principal enzyme is CYP27A1; in bacteria such as Mycobacterium smegmatis, CYP125A4 performs the same C-26 hydroxylation.
• Deficient activity causes cerebrotendinous xanthomatosis (CTX), marked by reduced serum 26-hydroxycholesterol and cholesterol accumulation.
• Cyp27a1 knockout mouse models reveal alternative sterol metabolic pathways and tissue-specific effects on brain and plasma sterols.
• Studying this activity requires mitochondrial reconstitution assays, isotope ratio analysis, and CRISPR-based gene editing to dissect enzyme function.
Description
Cholesterol 26-hydroxylase activity (GO:0031073) is a mitochondrial cytochrome P450-dependent molecular function that catalyzes the conversion of cholesterol to 26-hydroxycholesterol, a biologically active oxysterol involved in bile acid synthesis, cholesterol homeostasis, and immune regulation. This activity is essential for the initial step of the alternative bile acid pathway and for the generation of regulatory oxysterols that modulate lipid metabolism and inflammatory responses. Researchers study this activity to understand sterol metabolism in health and disease, particularly in neurodegenerative and cardiovascular disorders. The enzyme responsible, CYP27A1, is a mitochondrial inner membrane protein that requires NADPH and oxygen as cofactors. In addition to human CYP27A1, bacterial homologs such as CYP125A4 from Mycobacterium smegmatis have been characterized, providing structural and mechanistic insights into C-26 hydroxylation. The reaction is stereospecific and yields 26-hydroxycholesterol, which can be further metabolized to bile acids or act as a signaling molecule. This article integrates authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0031073, its genes, regulation, disease relevance, and experimental approaches for CRISPR-based research.
cholesterol 26-hydroxylase activity At A Glance
| GO ID | GO:0031073 |
|---|---|
| GO term | cholesterol 26-hydroxylase activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Catalysis of the reaction: cholesterol + H+ + NADPH + O2 = 26-hydroxycholesterol + H2O + NADP+. |
| Major function | Hydroxylation of cholesterol at C-26 to produce 26-hydroxycholesterol, a regulatory oxysterol and bile acid precursor. |
| Cofactors | NADPH, molecular oxygen, and cytochrome P450 heme iron. |
| Subcellular location | Mitochondrial inner membrane. |
| Representative enzyme | CYP27A1 (human), CYP125A4 (Mycobacterium smegmatis). |
What Is GO:0031073?
Cholesterol 26-hydroxylase activity (GO:0031073) is defined as the catalysis of the reaction: cholesterol + H+ + NADPH + O2 = 26-hydroxycholesterol + H2O + NADP+. This molecular function introduces a hydroxyl group at the C-26 position of the cholesterol side chain, a critical modification for sterol catabolism and signaling.
Why Is cholesterol 26-hydroxylase activity Important in Cell Biology?
Cholesterol 26-hydroxylase activity is critical for maintaining cholesterol homeostasis and generating oxysterols that regulate lipid metabolism, immune cell function, and bile acid synthesis. Its dysfunction leads to cerebrotendinous xanthomatosis, a rare autosomal recessive disorder characterized by cholesterol and cholestanol accumulation in tissues, neurological impairment, and premature atherosclerosis. The activity also influences systemic sterol balance, as shown by isotope ratio analysis in hamster liver mitochondria and reconstitution studies from bovine brain mitochondria. In ovarian mitochondria, 26-hydroxylation of cholesterol produces regulatory oxysterols that may affect reproductive physiology. Furthermore, bacterial homologs like CYP125A4 provide models for understanding the catalytic mechanism and for developing antimicrobial agents. Thus, GO:0031073 is a focal point for research in lipid biochemistry, neurobiology, and metabolic disease.
• Essential for the alternative bile acid synthesis pathway and cholesterol elimination.
• Generates 26-hydroxycholesterol, a potent regulator of cholesterol biosynthesis and immune responses.
• Deficiency causes cerebrotendinous xanthomatosis, a neurodegenerative disorder with xanthomas and premature atherosclerosis.
• Contributes to brain sterol metabolism, as evidenced by Cyp27a1-/- mouse studies showing altered brain sterol profiles.
• Involved in ovarian steroidogenesis and regulatory oxysterol production.
• Provides a target for understanding mitochondrial cytochrome P450 heterogeneity.
• Bacterial CYP125A4 offers a model for C-26 hydroxylation and potential drug targets.
• Reconstitution assays from bovine brain mitochondria enable detailed kinetic and mechanistic studies.
• Isotope ratio analysis using deuterated 26-hydroxycholesterol allows precise quantification in tissues.
• CRISPR-based editing of CYP27A1 can create isogenic models for disease and drug discovery.
What Happens During cholesterol 26-hydroxylase activity?
Substrate binding and activation
In simple terms: Cholesterol binds to the enzyme, which then uses oxygen and NADPH to add a hydroxyl group.
The enzyme, a mitochondrial cytochrome P450, binds cholesterol in its active site. The heme iron is reduced by NADPH via a redox partner system, enabling oxygen activation. This step is critical for regio-specific hydroxylation at C-26.
Catalytic hydroxylation
In simple terms: The enzyme inserts an oxygen atom into the cholesterol side chain at carbon 26.
Following oxygen activation, the enzyme catalyzes the insertion of a hydroxyl group at the C-26 position of the cholesterol side chain, yielding 26-hydroxycholesterol. This reaction is stereospecific and requires NADPH and molecular oxygen.
Product release and downstream metabolism
In simple terms: The product, 26-hydroxycholesterol, is released and can be further converted to bile acids or act as a signal.
26-Hydroxycholesterol is released from the active site and can undergo further oxidation to bile acids in the liver or serve as a signaling molecule regulating cholesterol homeostasis and immune function. In brain, it contributes to local sterol metabolism.
Tissue-specific regulation
In simple terms: Different tissues have different levels of this enzyme activity, affecting local sterol metabolism.
The activity is present in liver, brain, ovary, and other tissues, with tissue-specific regulation. For example, ovarian mitochondria generate regulatory oxysterols via 26-hydroxylation, while brain mitochondria from bovine sources show reconstitutable activity. Cyp27a1-/- mice exhibit altered brain and plasma sterol profiles, indicating tissue-specific roles.
Key Genes Involved in GO:0031073 cholesterol 26-hydroxylase activity
The following genes and proteins are directly implicated in cholesterol 26-hydroxylase activity or its regulation, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP27A1 | Human mitochondrial cytochrome P450 responsible for cholesterol 26-hydroxylase activity | Mutations cause cerebrotendinous xanthomatosis; target for gene editing |
| CYP125A4 | Bacterial cytochrome P450 from Mycobacterium smegmatis with C-26 hydroxylase activity | Model for mechanistic and structural studies |
| FDX1 | Ferredoxin, electron donor to mitochondrial P450s | Supports CYP27A1 activity; potential knockout target |
| FDXR | Ferredoxin reductase, transfers electrons from NADPH to ferredoxin | Essential for mitochondrial P450 function; knockout affects activity |
| NR1H2 (LXRβ) | Nuclear receptor responsive to oxysterols | Regulates cholesterol homeostasis; may feedback on CYP27A1 |
| NR1H3 (LXRα) | Nuclear receptor activated by oxysterols | Links 26-hydroxycholesterol to lipid metabolism |
| SREBF2 | Master regulator of cholesterol biosynthesis | May be affected by 26-hydroxycholesterol levels |
| HMGCR | Rate-limiting enzyme in cholesterol synthesis | Target of feedback regulation by oxysterols |
| CYP7A1 | Classical bile acid synthesis enzyme | Compensatory pathway when CYP27A1 is deficient |
| CYP7B1 | Alternative bile acid synthesis enzyme | Oxysterol 7α-hydroxylase; downstream of 26-hydroxycholesterol |
| ABCA1 | Cholesterol efflux transporter | Regulated by oxysterols; affects cellular cholesterol |
| APOE | Lipoprotein involved in cholesterol transport | Modifies disease phenotype in CTX models |
| STAR | Steroidogenic acute regulatory protein | Delivers cholesterol to mitochondria for hydroxylation |
| TSPO | Mitochondrial cholesterol transport protein | Facilitates cholesterol import for CYP27A1 |
| VDAC1 | Mitochondrial porin | May interact with cholesterol transport machinery |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | Competes with CYP27A1 for cholesterol substrate |
| CYP46A1 | Cholesterol 24-hydroxylase | Brain-specific oxysterol pathway; complementary to CYP27A1 |
| NR0B2 (SHP) | Small heterodimer partner | Regulates bile acid synthesis feedback |
How Is cholesterol 26-hydroxylase activity Regulated?
Cholesterol 26-hydroxylase activity is regulated at multiple levels. Transcriptional regulation of CYP27A1 is influenced by bile acids, oxysterols, and nuclear receptors such as LXR and FXR. Post-translational regulation includes phosphorylation and interaction with redox partners FDX1 and FDXR, which modulate electron transfer efficiency. In brain, Cyp27a1 expression is regulated during development and in response to injury, as shown in knockout mouse studies. Hormonal signals also affect activity; ovarian mitochondria exhibit regulated 26-hydroxylation, potentially linked to steroidogenesis. Additionally, substrate availability via STAR and TSPO-mediated cholesterol transport into mitochondria is a key control point.
cholesterol 26-hydroxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP27A1 | Cerebrotendinous xanthomatosis; sterol accumulation | CYP27A1 knockout iPSCs or HepG2 cells; mouse Cyp27a1-/- |
| CYP27A1 | Neurodegeneration; brain sterol imbalance | Neuron-specific Cyp27a1 knockout mice; human neuronal cultures |
| CYP27A1 | Cardiovascular disease; oxysterol signaling | ApoE-/- background with Cyp27a1 knockout; macrophage models |
| FDX1/FDXR | Mitochondrial P450 electron transfer deficiency | Knockout cell lines; reconstitution assays |
| CYP125A4 | Bacterial sterol metabolism; drug target | Mycobacterium smegmatis knockout and complementation |
Cerebrotendinous xanthomatosis (CTX)
CTX is an autosomal recessive disorder caused by mutations in CYP27A1, leading to deficient cholesterol 26-hydroxylase activity. Patients exhibit reduced serum 26-hydroxycholesterol, cholesterol and cholestanol accumulation in tissues, tendon xanthomas, cataracts, and progressive neurological dysfunction. The disease highlights the critical role of GO:0031073 in sterol metabolism and neuroprotection.
Neurodegeneration and brain sterol metabolism
Cyp27a1-/- mouse models show altered brain sterol profiles, including accumulation of cholesterol precursors and reduced 26-hydroxycholesterol, suggesting a role for this activity in brain cholesterol homeostasis and neuronal function. These findings link GO:0031073 to neurodegenerative processes and potential therapeutic targets.
Cardiovascular and metabolic disorders
26-Hydroxycholesterol, the product of GO:0031073, is a ligand for LXR and modulates cholesterol efflux, inflammation, and atherosclerosis. Dysregulated activity may contribute to cardiovascular disease and metabolic syndrome. Ovarian 26-hydroxylation also produces regulatory oxysterols that may influence reproductive and metabolic health.
From cholesterol 26-hydroxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP27A1 abolish 26-hydroxylase activity? | CYP27A1 knockout cell line (e.g., HepG2, HEK293) via CRISPR |
| What is the effect of a specific point mutation on enzyme kinetics? | Point-mutation knock-in of CYP27A1 (e.g., CTX-associated variants) in isogenic cells |
| Can we tag CYP27A1 to track its localization? | Knock-in of fluorescent or epitope tag at endogenous locus |
| Does overexpression of CYP27A1 increase 26-hydroxycholesterol production? | Overexpression of CYP27A1 in cell lines or primary cells |
| What genes modify the CTX phenotype? | CRISPR library screening in CYP27A1 knockout cells |
| How does CYP27A1 activity affect global sterol profiles? | Metabolomics and lipidomics in knockout vs. wild-type cells |
How to Study the cholesterol 26-hydroxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isotope ratio analysis | 26-Hydroxycholesterol levels using deuterated internal standard | Quantification in liver mitochondria |
| Reconstitution assay | Enzymatic conversion of cholesterol to 26-hydroxycholesterol | Mitochondrial P450 activity |
| LC-MS/MS lipidomics | Sterol and oxysterol profiles | Knockout vs. wild-type comparison |
| CRISPR knockout | Gene function loss | CYP27A1 knockout in cell lines |
| CRISPR point mutation | Specific amino acid substitution | Modeling CTX mutations |
| CRISPR knock-in | Tagged or reporter gene | Localization and interaction studies |
| Overexpression | Increased enzyme levels | Gain-of-function studies |
| RNA-seq | Transcriptional changes | Pathway analysis in edited cells |
Enzyme activity assays
Reconstitution of cholesterol 26-hydroxylase activity from mitochondria or recombinant enzyme allows direct measurement of product formation. Isotope ratio analysis using deuterated 26-hydroxycholesterol enables precise quantification in tissues.
Genetic and CRISPR screens
CRISPR knockout, point mutation, and knock-in models can dissect the role of CYP27A1 and its partners. Library screening identifies modifiers of 26-hydroxycholesterol levels and CTX-related phenotypes.
Metabolomics and lipidomics
Mass spectrometry-based sterol profiling quantifies cholesterol, 26-hydroxycholesterol, and bile acids in cells and tissues, revealing metabolic consequences of altered activity.
Imaging and subcellular localization
Fluorescent tagging of CYP27A1 or its partners allows visualization of mitochondrial localization and trafficking in live cells.
How CRISPR Can Be Used to Study GO:0031073 cholesterol 26-hydroxylase activity
Knockout
CRISPR knockout of CYP27A1 or its redox partners (FDX1, FDXR) creates isogenic models to study loss of cholesterol 26-hydroxylase activity, mimicking CTX. These models are useful for lipidomics, drug screening, and pathway analysis.
Point Mutation
Introducing specific CTX-associated point mutations (e.g., in CYP27A1) via CRISPR base editing or HDR allows structure-function studies and personalized disease modeling without confounding background mutations.
Knock-in
Knock-in of fluorescent or epitope tags at the endogenous CYP27A1 locus enables real-time tracking of enzyme localization and interaction with mitochondria. Knock-in of reporter genes can monitor activity in live cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CYP27A1 increases 26-hydroxylase activity, useful for gain-of-function studies and producing 26-hydroxycholesterol for downstream assays.
How EDITGENE Supports cholesterol 26-hydroxylase activity Research
Researchers studying cholesterol 26-hydroxylase activity-related genes often need to determine whether a candidate gene is causally involved in oxysterol production, mitochondrial sterol metabolism, or disease phenotypes. EDITGENE provides end-to-end CRISPR solutions to generate precisely edited cell models, enabling rigorous mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for cholesterol 26-hydroxylase activity research.
Frequently Asked Questions About cholesterol 26-hydroxylase activity
What is cholesterol 26-hydroxylase activity?
Cholesterol 26-hydroxylase activity (GO:0031073) is a molecular function that catalyzes the conversion of cholesterol to 26-hydroxycholesterol using NADPH and oxygen, primarily performed by the mitochondrial enzyme CYP27A1.
What genes are involved in cholesterol 26-hydroxylase activity?
The main human gene is CYP27A1. Other supporting genes include FDX1, FDXR, and cholesterol transport proteins like STAR and TSPO. Bacterial homolog CYP125A4 also performs this activity.
What is the role of CYP27A1 in disease?
Mutations in CYP27A1 cause cerebrotendinous xanthomatosis (CTX), characterized by reduced serum 26-hydroxycholesterol, cholesterol accumulation, and neurological symptoms.
How is cholesterol 26-hydroxylase activity measured?
It can be measured by reconstitution assays using mitochondria or recombinant enzyme, often coupled with isotope ratio analysis using deuterated 26-hydroxycholesterol.
What is 26-hydroxycholesterol?
26-Hydroxycholesterol is the product of GO:0031073. It is a regulatory oxysterol involved in bile acid synthesis, cholesterol homeostasis, and immune modulation.
Can CRISPR be used to study cholesterol 26-hydroxylase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function and disease mechanisms related to this activity.
What animal models exist for cholesterol 26-hydroxylase deficiency?
Cyp27a1-/- mice are widely used and exhibit altered brain and plasma sterol profiles, mimicking aspects of CTX.
Is cholesterol 26-hydroxylase activity present in bacteria?
Yes, Mycobacterium smegmatis CYP125A4 is a bacterial enzyme with C-26 hydroxylase activity, serving as a model for mechanistic studies.
What tissues express cholesterol 26-hydroxylase activity?
It is found in liver, brain, ovary, and other tissues, with tissue-specific regulation and roles in local sterol metabolism.
How does 26-hydroxycholesterol affect cholesterol synthesis?
26-Hydroxycholesterol can inhibit HMG-CoA reductase and activate LXR, thereby reducing cholesterol synthesis and increasing efflux.
Conclusion
Cholesterol 26-hydroxylase activity (GO:0031073) is a fundamental mitochondrial molecular function that governs the production of 26-hydroxycholesterol, a key regulatory oxysterol. Its dysfunction is directly linked to cerebrotendinous xanthomatosis and contributes to broader metabolic and neurodegenerative pathologies. The enzyme CYP27A1 and its bacterial homolog CYP125A4 provide valuable models for mechanistic studies. Advances in CRISPR gene editing now enable precise modeling of this activity in human cells, facilitating drug discovery and personalized medicine. Continued research into GO:0031073 will illuminate sterol metabolism and open new therapeutic avenues.
References
- 1. Frank DJ et al.. 2015. Cytochrome P450 125A4, the Third Cholesterol C-26 Hydroxylase from Mycobacterium smegmatis.. Biochemistry 54(46):6909-16 PMID: 26522442
- 2. Kok E et al.. 1990. Cholesterol 26-hydroxylase activity of hamster liver mitochondria: isotope ratio analysis using deuterated 26-hydroxycholesterol.. J Lipid Res 31(4):735-8 PMID: 2351877
- 3. Pedersen JI et al.. 1989. Reconstitution of C27-steroid 26-hydroxylase activity from bovine brain mitochondria.. Biochem Int 18(3):615-22 PMID: 2764966
- 4. Rennert H et al.. 1990. Generation of regulatory oxysterols: 26-hydroxylation of cholesterol by ovarian mitochondria.. Endocrinology 127(2):738-46 PMID: 2373053
- 5. Javitt NB. 1990. 26-Hydroxycholesterol: synthesis, metabolism, and biologic activities.. J Lipid Res 31(9):1527-33 PMID: 2246606
- 6. Javitt NB et al.. 1982. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.. J Lipid Res 23(4):627-30 PMID: 7097127
- 7. Gustafsson J. 1976. On the heterogeneity of the mitochondrial C27-steroid 26-hydroxylase system.. J Lipid Res 17(4):366-72 PMID: 950499
- 8. Griffiths WJ et al.. 2019. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.. Biochim Biophys Acta Mol Cell Biol Lipids 1864(2):191-211 PMID: 30471425
